000 | 01948 a2200541 4500 | ||
---|---|---|---|
005 | 20250516011810.0 | ||
264 | 0 | _c20110113 | |
008 | 201101s 0 0 eng d | ||
022 | _a1097-685X | ||
024 | 7 |
_a10.1016/j.jtcvs.2010.09.011 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKuppusamy, Madhankumar | |
245 | 0 | 0 |
_aIn an era of health reform: defining cost differences in current esophageal cancer management strategies and assessing the cost of complications. _h[electronic resource] |
260 |
_bThe Journal of thoracic and cardiovascular surgery _cJan 2011 |
||
300 |
_a16-21 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
650 | 0 | 4 |
_aChemotherapy, Adjuvant _xeconomics |
650 | 0 | 4 | _aCost Savings |
650 | 0 | 4 | _aCost-Benefit Analysis |
650 | 0 | 4 | _aDrug Costs |
650 | 0 | 4 |
_aEsophageal Neoplasms _xdiagnosis |
650 | 0 | 4 |
_aEsophagectomy _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHealth Care Costs |
650 | 0 | 4 |
_aHealth Care Reform _xeconomics |
650 | 0 | 4 | _aHealth Services Research |
650 | 0 | 4 | _aHospital Costs |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aModels, Economic |
650 | 0 | 4 |
_aNeoadjuvant Therapy _xeconomics |
650 | 0 | 4 |
_aOutcome and Process Assessment, Health Care _xeconomics |
650 | 0 | 4 |
_aPostoperative Complications _xeconomics |
650 | 0 | 4 |
_aRadiation Injuries _xeconomics |
650 | 0 | 4 |
_aRadiotherapy, Adjuvant _xeconomics |
650 | 0 | 4 | _aRegistries |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aWisconsin |
700 | 1 | _aSylvester, Julie | |
700 | 1 | _aLow, Donald E | |
773 | 0 |
_tThe Journal of thoracic and cardiovascular surgery _gvol. 141 _gno. 1 _gp. 16-21 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jtcvs.2010.09.011 _zAvailable from publisher's website |
999 |
_c20346879 _d20346879 |